Global Latent Tuberculosis Infection Screening Test Supply, Demand and Key Producers, 2023-2029
The global Latent Tuberculosis Infection Screening Test market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Latent tuberculosis infection (LTBI) screening tests are diagnostic tests used to identify individuals who have been infected with the bacteria that cause tuberculosis (TB) but do not have any active symptoms of the disease. LTBI screening is crucial for early detection and treatment of latent infections to prevent the development of active TB disease and transmission to others.
This report studies the global Latent Tuberculosis Infection Screening Test demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Latent Tuberculosis Infection Screening Test, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Latent Tuberculosis Infection Screening Test that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Latent Tuberculosis Infection Screening Test total market, 2018-2029, (USD Million)
Global Latent Tuberculosis Infection Screening Test total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Latent Tuberculosis Infection Screening Test total market, key domestic companies and share, (USD Million)
Global Latent Tuberculosis Infection Screening Test revenue by player and market share 2018-2023, (USD Million)
Global Latent Tuberculosis Infection Screening Test total market by Type, CAGR, 2018-2029, (USD Million)
Global Latent Tuberculosis Infection Screening Test total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Latent Tuberculosis Infection Screening Test market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi and Par Sterile, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Latent Tuberculosis Infection Screening Test market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Latent Tuberculosis Infection Screening Test Market, By Region:
1. How big is the global Latent Tuberculosis Infection Screening Test market?
2. What is the demand of the global Latent Tuberculosis Infection Screening Test market?
3. What is the year over year growth of the global Latent Tuberculosis Infection Screening Test market?
4. What is the total value of the global Latent Tuberculosis Infection Screening Test market?
5. Who are the major players in the global Latent Tuberculosis Infection Screening Test market?
6. What are the growth factors driving the market demand?
Latent tuberculosis infection (LTBI) screening tests are diagnostic tests used to identify individuals who have been infected with the bacteria that cause tuberculosis (TB) but do not have any active symptoms of the disease. LTBI screening is crucial for early detection and treatment of latent infections to prevent the development of active TB disease and transmission to others.
This report studies the global Latent Tuberculosis Infection Screening Test demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Latent Tuberculosis Infection Screening Test, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Latent Tuberculosis Infection Screening Test that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Latent Tuberculosis Infection Screening Test total market, 2018-2029, (USD Million)
Global Latent Tuberculosis Infection Screening Test total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Latent Tuberculosis Infection Screening Test total market, key domestic companies and share, (USD Million)
Global Latent Tuberculosis Infection Screening Test revenue by player and market share 2018-2023, (USD Million)
Global Latent Tuberculosis Infection Screening Test total market by Type, CAGR, 2018-2029, (USD Million)
Global Latent Tuberculosis Infection Screening Test total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Latent Tuberculosis Infection Screening Test market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen, Oxford Immunotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Sanofi and Par Sterile, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Latent Tuberculosis Infection Screening Test market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Latent Tuberculosis Infection Screening Test Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
- Hospital
- Diagnostic Laboratories
- Others
- Qiagen
- Oxford Immunotec
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Sanofi
- Par Sterile
1. How big is the global Latent Tuberculosis Infection Screening Test market?
2. What is the demand of the global Latent Tuberculosis Infection Screening Test market?
3. What is the year over year growth of the global Latent Tuberculosis Infection Screening Test market?
4. What is the total value of the global Latent Tuberculosis Infection Screening Test market?
5. Who are the major players in the global Latent Tuberculosis Infection Screening Test market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Latent Tuberculosis Infection Screening Test Introduction
1.2 World Latent Tuberculosis Infection Screening Test Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Latent Tuberculosis Infection Screening Test Total Market by Region (by Headquarter Location)
1.3.1 World Latent Tuberculosis Infection Screening Test Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.3 China Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.4 Europe Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.5 Japan Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.6 South Korea Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.7 ASEAN Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.8 India Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Latent Tuberculosis Infection Screening Test Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Latent Tuberculosis Infection Screening Test Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.2 World Latent Tuberculosis Infection Screening Test Consumption Value by Region
2.2.1 World Latent Tuberculosis Infection Screening Test Consumption Value by Region (2018-2023)
2.2.2 World Latent Tuberculosis Infection Screening Test Consumption Value Forecast by Region (2024-2029)
2.3 United States Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.4 China Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.5 Europe Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.6 Japan Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.7 South Korea Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.8 ASEAN Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.9 India Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
3 WORLD LATENT TUBERCULOSIS INFECTION SCREENING TEST COMPANIES COMPETITIVE ANALYSIS
3.1 World Latent Tuberculosis Infection Screening Test Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Latent Tuberculosis Infection Screening Test Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Latent Tuberculosis Infection Screening Test in 2022
3.2.3 Global Concentration Ratios (CR8) for Latent Tuberculosis Infection Screening Test in 2022
3.3 Latent Tuberculosis Infection Screening Test Company Evaluation Quadrant
3.4 Latent Tuberculosis Infection Screening Test Market: Overall Company Footprint Analysis
3.4.1 Latent Tuberculosis Infection Screening Test Market: Region Footprint
3.4.2 Latent Tuberculosis Infection Screening Test Market: Company Product Type Footprint
3.4.3 Latent Tuberculosis Infection Screening Test Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Latent Tuberculosis Infection Screening Test Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Latent Tuberculosis Infection Screening Test Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Latent Tuberculosis Infection Screening Test Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Latent Tuberculosis Infection Screening Test Consumption Value Comparison
4.2.1 United States VS China: Latent Tuberculosis Infection Screening Test Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Latent Tuberculosis Infection Screening Test Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Latent Tuberculosis Infection Screening Test Companies and Market Share, 2018-2023
4.3.1 United States Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023)
4.4 China Based Companies Latent Tuberculosis Infection Screening Test Revenue and Market Share, 2018-2023
4.4.1 China Based Latent Tuberculosis Infection Screening Test Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023)
4.5 Rest of World Based Latent Tuberculosis Infection Screening Test Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Latent Tuberculosis Infection Screening Test Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tuberculin Skin Test (TST)
5.2.2 Interferon Gamma Released Assay (IGRA)
5.3 Market Segment by Type
5.3.1 World Latent Tuberculosis Infection Screening Test Market Size by Type (2018-2023)
5.3.2 World Latent Tuberculosis Infection Screening Test Market Size by Type (2024-2029)
5.3.3 World Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Latent Tuberculosis Infection Screening Test Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Diagnostic Laboratories
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Latent Tuberculosis Infection Screening Test Market Size by Application (2018-2023)
6.3.2 World Latent Tuberculosis Infection Screening Test Market Size by Application (2024-2029)
6.3.3 World Latent Tuberculosis Infection Screening Test Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Qiagen
7.1.1 Qiagen Details
7.1.2 Qiagen Major Business
7.1.3 Qiagen Latent Tuberculosis Infection Screening Test Product and Services
7.1.4 Qiagen Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Qiagen Recent Developments/Updates
7.1.6 Qiagen Competitive Strengths & Weaknesses
7.2 Oxford Immunotec
7.2.1 Oxford Immunotec Details
7.2.2 Oxford Immunotec Major Business
7.2.3 Oxford Immunotec Latent Tuberculosis Infection Screening Test Product and Services
7.2.4 Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Oxford Immunotec Recent Developments/Updates
7.2.6 Oxford Immunotec Competitive Strengths & Weaknesses
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Details
7.3.2 Bio-Rad Laboratories Major Business
7.3.3 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product and Services
7.3.4 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Rad Laboratories Recent Developments/Updates
7.3.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product and Services
7.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Latent Tuberculosis Infection Screening Test Product and Services
7.5.4 Sanofi Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Par Sterile
7.6.1 Par Sterile Details
7.6.2 Par Sterile Major Business
7.6.3 Par Sterile Latent Tuberculosis Infection Screening Test Product and Services
7.6.4 Par Sterile Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Par Sterile Recent Developments/Updates
7.6.6 Par Sterile Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Latent Tuberculosis Infection Screening Test Industry Chain
8.2 Latent Tuberculosis Infection Screening Test Upstream Analysis
8.3 Latent Tuberculosis Infection Screening Test Midstream Analysis
8.4 Latent Tuberculosis Infection Screening Test Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Latent Tuberculosis Infection Screening Test Introduction
1.2 World Latent Tuberculosis Infection Screening Test Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Latent Tuberculosis Infection Screening Test Total Market by Region (by Headquarter Location)
1.3.1 World Latent Tuberculosis Infection Screening Test Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.3 China Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.4 Europe Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.5 Japan Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.6 South Korea Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.7 ASEAN Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.3.8 India Latent Tuberculosis Infection Screening Test Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Latent Tuberculosis Infection Screening Test Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Latent Tuberculosis Infection Screening Test Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.2 World Latent Tuberculosis Infection Screening Test Consumption Value by Region
2.2.1 World Latent Tuberculosis Infection Screening Test Consumption Value by Region (2018-2023)
2.2.2 World Latent Tuberculosis Infection Screening Test Consumption Value Forecast by Region (2024-2029)
2.3 United States Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.4 China Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.5 Europe Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.6 Japan Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.7 South Korea Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.8 ASEAN Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
2.9 India Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029)
3 WORLD LATENT TUBERCULOSIS INFECTION SCREENING TEST COMPANIES COMPETITIVE ANALYSIS
3.1 World Latent Tuberculosis Infection Screening Test Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Latent Tuberculosis Infection Screening Test Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Latent Tuberculosis Infection Screening Test in 2022
3.2.3 Global Concentration Ratios (CR8) for Latent Tuberculosis Infection Screening Test in 2022
3.3 Latent Tuberculosis Infection Screening Test Company Evaluation Quadrant
3.4 Latent Tuberculosis Infection Screening Test Market: Overall Company Footprint Analysis
3.4.1 Latent Tuberculosis Infection Screening Test Market: Region Footprint
3.4.2 Latent Tuberculosis Infection Screening Test Market: Company Product Type Footprint
3.4.3 Latent Tuberculosis Infection Screening Test Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Latent Tuberculosis Infection Screening Test Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Latent Tuberculosis Infection Screening Test Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Latent Tuberculosis Infection Screening Test Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Latent Tuberculosis Infection Screening Test Consumption Value Comparison
4.2.1 United States VS China: Latent Tuberculosis Infection Screening Test Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Latent Tuberculosis Infection Screening Test Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Latent Tuberculosis Infection Screening Test Companies and Market Share, 2018-2023
4.3.1 United States Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023)
4.4 China Based Companies Latent Tuberculosis Infection Screening Test Revenue and Market Share, 2018-2023
4.4.1 China Based Latent Tuberculosis Infection Screening Test Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023)
4.5 Rest of World Based Latent Tuberculosis Infection Screening Test Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Latent Tuberculosis Infection Screening Test Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tuberculin Skin Test (TST)
5.2.2 Interferon Gamma Released Assay (IGRA)
5.3 Market Segment by Type
5.3.1 World Latent Tuberculosis Infection Screening Test Market Size by Type (2018-2023)
5.3.2 World Latent Tuberculosis Infection Screening Test Market Size by Type (2024-2029)
5.3.3 World Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Latent Tuberculosis Infection Screening Test Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Diagnostic Laboratories
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Latent Tuberculosis Infection Screening Test Market Size by Application (2018-2023)
6.3.2 World Latent Tuberculosis Infection Screening Test Market Size by Application (2024-2029)
6.3.3 World Latent Tuberculosis Infection Screening Test Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Qiagen
7.1.1 Qiagen Details
7.1.2 Qiagen Major Business
7.1.3 Qiagen Latent Tuberculosis Infection Screening Test Product and Services
7.1.4 Qiagen Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Qiagen Recent Developments/Updates
7.1.6 Qiagen Competitive Strengths & Weaknesses
7.2 Oxford Immunotec
7.2.1 Oxford Immunotec Details
7.2.2 Oxford Immunotec Major Business
7.2.3 Oxford Immunotec Latent Tuberculosis Infection Screening Test Product and Services
7.2.4 Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Oxford Immunotec Recent Developments/Updates
7.2.6 Oxford Immunotec Competitive Strengths & Weaknesses
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Details
7.3.2 Bio-Rad Laboratories Major Business
7.3.3 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product and Services
7.3.4 Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Bio-Rad Laboratories Recent Developments/Updates
7.3.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product and Services
7.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi Latent Tuberculosis Infection Screening Test Product and Services
7.5.4 Sanofi Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Par Sterile
7.6.1 Par Sterile Details
7.6.2 Par Sterile Major Business
7.6.3 Par Sterile Latent Tuberculosis Infection Screening Test Product and Services
7.6.4 Par Sterile Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Par Sterile Recent Developments/Updates
7.6.6 Par Sterile Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Latent Tuberculosis Infection Screening Test Industry Chain
8.2 Latent Tuberculosis Infection Screening Test Upstream Analysis
8.3 Latent Tuberculosis Infection Screening Test Midstream Analysis
8.4 Latent Tuberculosis Infection Screening Test Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Latent Tuberculosis Infection Screening Test Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Latent Tuberculosis Infection Screening Test Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Latent Tuberculosis Infection Screening Test Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Latent Tuberculosis Infection Screening Test Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Latent Tuberculosis Infection Screening Test Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Latent Tuberculosis Infection Screening Test Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Latent Tuberculosis Infection Screening Test Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Latent Tuberculosis Infection Screening Test Players in 2022
Table 12. World Latent Tuberculosis Infection Screening Test Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Latent Tuberculosis Infection Screening Test Company Evaluation Quadrant
Table 14. Head Office of Key Latent Tuberculosis Infection Screening Test Player
Table 15. Latent Tuberculosis Infection Screening Test Market: Company Product Type Footprint
Table 16. Latent Tuberculosis Infection Screening Test Market: Company Product Application Footprint
Table 17. Latent Tuberculosis Infection Screening Test Mergers & Acquisitions Activity
Table 18. United States VS China Latent Tuberculosis Infection Screening Test Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Latent Tuberculosis Infection Screening Test Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
Table 21. United States Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Latent Tuberculosis Infection Screening Test Revenue Market Share (2018-2023)
Table 23. China Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (Province, Country)
Table 24. China Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Latent Tuberculosis Infection Screening Test Revenue Market Share (2018-2023)
Table 26. Rest of World Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Latent Tuberculosis Infection Screening Test Revenue Market Share (2018-2023)
Table 29. World Latent Tuberculosis Infection Screening Test Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Latent Tuberculosis Infection Screening Test Market Size by Type (2018-2023) & (USD Million)
Table 31. World Latent Tuberculosis Infection Screening Test Market Size by Type (2024-2029) & (USD Million)
Table 32. World Latent Tuberculosis Infection Screening Test Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Latent Tuberculosis Infection Screening Test Market Size by Application (2018-2023) & (USD Million)
Table 34. World Latent Tuberculosis Infection Screening Test Market Size by Application (2024-2029) & (USD Million)
Table 35. Qiagen Basic Information, Area Served and Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Latent Tuberculosis Infection Screening Test Product and Services
Table 38. Qiagen Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Qiagen Recent Developments/Updates
Table 40. Qiagen Competitive Strengths & Weaknesses
Table 41. Oxford Immunotec Basic Information, Area Served and Competitors
Table 42. Oxford Immunotec Major Business
Table 43. Oxford Immunotec Latent Tuberculosis Infection Screening Test Product and Services
Table 44. Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Oxford Immunotec Recent Developments/Updates
Table 46. Oxford Immunotec Competitive Strengths & Weaknesses
Table 47. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 48. Bio-Rad Laboratories Major Business
Table 49. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product and Services
Table 50. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bio-Rad Laboratories Recent Developments/Updates
Table 52. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product and Services
Table 56. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Sanofi Basic Information, Area Served and Competitors
Table 60. Sanofi Major Business
Table 61. Sanofi Latent Tuberculosis Infection Screening Test Product and Services
Table 62. Sanofi Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sanofi Recent Developments/Updates
Table 64. Par Sterile Basic Information, Area Served and Competitors
Table 65. Par Sterile Major Business
Table 66. Par Sterile Latent Tuberculosis Infection Screening Test Product and Services
Table 67. Par Sterile Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Latent Tuberculosis Infection Screening Test Upstream (Raw Materials)
Table 69. Latent Tuberculosis Infection Screening Test Typical Customers
Table 1. World Latent Tuberculosis Infection Screening Test Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Latent Tuberculosis Infection Screening Test Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Latent Tuberculosis Infection Screening Test Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Latent Tuberculosis Infection Screening Test Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Latent Tuberculosis Infection Screening Test Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Latent Tuberculosis Infection Screening Test Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Latent Tuberculosis Infection Screening Test Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Latent Tuberculosis Infection Screening Test Players in 2022
Table 12. World Latent Tuberculosis Infection Screening Test Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Latent Tuberculosis Infection Screening Test Company Evaluation Quadrant
Table 14. Head Office of Key Latent Tuberculosis Infection Screening Test Player
Table 15. Latent Tuberculosis Infection Screening Test Market: Company Product Type Footprint
Table 16. Latent Tuberculosis Infection Screening Test Market: Company Product Application Footprint
Table 17. Latent Tuberculosis Infection Screening Test Mergers & Acquisitions Activity
Table 18. United States VS China Latent Tuberculosis Infection Screening Test Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Latent Tuberculosis Infection Screening Test Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
Table 21. United States Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Latent Tuberculosis Infection Screening Test Revenue Market Share (2018-2023)
Table 23. China Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (Province, Country)
Table 24. China Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Latent Tuberculosis Infection Screening Test Revenue Market Share (2018-2023)
Table 26. Rest of World Based Latent Tuberculosis Infection Screening Test Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Latent Tuberculosis Infection Screening Test Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Latent Tuberculosis Infection Screening Test Revenue Market Share (2018-2023)
Table 29. World Latent Tuberculosis Infection Screening Test Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Latent Tuberculosis Infection Screening Test Market Size by Type (2018-2023) & (USD Million)
Table 31. World Latent Tuberculosis Infection Screening Test Market Size by Type (2024-2029) & (USD Million)
Table 32. World Latent Tuberculosis Infection Screening Test Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Latent Tuberculosis Infection Screening Test Market Size by Application (2018-2023) & (USD Million)
Table 34. World Latent Tuberculosis Infection Screening Test Market Size by Application (2024-2029) & (USD Million)
Table 35. Qiagen Basic Information, Area Served and Competitors
Table 36. Qiagen Major Business
Table 37. Qiagen Latent Tuberculosis Infection Screening Test Product and Services
Table 38. Qiagen Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Qiagen Recent Developments/Updates
Table 40. Qiagen Competitive Strengths & Weaknesses
Table 41. Oxford Immunotec Basic Information, Area Served and Competitors
Table 42. Oxford Immunotec Major Business
Table 43. Oxford Immunotec Latent Tuberculosis Infection Screening Test Product and Services
Table 44. Oxford Immunotec Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Oxford Immunotec Recent Developments/Updates
Table 46. Oxford Immunotec Competitive Strengths & Weaknesses
Table 47. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 48. Bio-Rad Laboratories Major Business
Table 49. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Product and Services
Table 50. Bio-Rad Laboratories Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Bio-Rad Laboratories Recent Developments/Updates
Table 52. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Product and Services
Table 56. Thermo Fisher Scientific Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Sanofi Basic Information, Area Served and Competitors
Table 60. Sanofi Major Business
Table 61. Sanofi Latent Tuberculosis Infection Screening Test Product and Services
Table 62. Sanofi Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sanofi Recent Developments/Updates
Table 64. Par Sterile Basic Information, Area Served and Competitors
Table 65. Par Sterile Major Business
Table 66. Par Sterile Latent Tuberculosis Infection Screening Test Product and Services
Table 67. Par Sterile Latent Tuberculosis Infection Screening Test Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Latent Tuberculosis Infection Screening Test Upstream (Raw Materials)
Table 69. Latent Tuberculosis Infection Screening Test Typical Customers
LIST OF FIGURES
Figure 1. Latent Tuberculosis Infection Screening Test Picture
Figure 2. World Latent Tuberculosis Infection Screening Test Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Latent Tuberculosis Infection Screening Test Total Market Size (2018-2029) & (USD Million)
Figure 4. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 13. Latent Tuberculosis Infection Screening Test Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 16. World Latent Tuberculosis Infection Screening Test Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 18. China Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 23. India Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Latent Tuberculosis Infection Screening Test by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Latent Tuberculosis Infection Screening Test Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Latent Tuberculosis Infection Screening Test Markets in 2022
Figure 27. United States VS China: Latent Tuberculosis Infection Screening Test Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Latent Tuberculosis Infection Screening Test Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Latent Tuberculosis Infection Screening Test Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Latent Tuberculosis Infection Screening Test Market Size Market Share by Type in 2022
Figure 31. Tuberculin Skin Test (TST)
Figure 32. Interferon Gamma Released Assay (IGRA)
Figure 33. World Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2018-2029)
Figure 34. World Latent Tuberculosis Infection Screening Test Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Latent Tuberculosis Infection Screening Test Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Diagnostic Laboratories
Figure 38. Others
Figure 39. Latent Tuberculosis Infection Screening Test Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Latent Tuberculosis Infection Screening Test Picture
Figure 2. World Latent Tuberculosis Infection Screening Test Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Latent Tuberculosis Infection Screening Test Total Market Size (2018-2029) & (USD Million)
Figure 4. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Latent Tuberculosis Infection Screening Test Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Latent Tuberculosis Infection Screening Test Revenue (2018-2029) & (USD Million)
Figure 13. Latent Tuberculosis Infection Screening Test Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 16. World Latent Tuberculosis Infection Screening Test Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 18. China Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 23. India Latent Tuberculosis Infection Screening Test Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Latent Tuberculosis Infection Screening Test by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Latent Tuberculosis Infection Screening Test Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Latent Tuberculosis Infection Screening Test Markets in 2022
Figure 27. United States VS China: Latent Tuberculosis Infection Screening Test Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Latent Tuberculosis Infection Screening Test Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Latent Tuberculosis Infection Screening Test Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Latent Tuberculosis Infection Screening Test Market Size Market Share by Type in 2022
Figure 31. Tuberculin Skin Test (TST)
Figure 32. Interferon Gamma Released Assay (IGRA)
Figure 33. World Latent Tuberculosis Infection Screening Test Market Size Market Share by Type (2018-2029)
Figure 34. World Latent Tuberculosis Infection Screening Test Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Latent Tuberculosis Infection Screening Test Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Diagnostic Laboratories
Figure 38. Others
Figure 39. Latent Tuberculosis Infection Screening Test Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
